96 related articles for article (PubMed ID: 2902101)
1. Analysis of a new H2 receptor antagonist, 3-amino-5-[3-[4-(1-piperidinoindanyloxy)]propylamino]-1-methyl-1 H-1,2,4-triazole, in human plasma and urine by high-performance liquid chromatography.
Miksic JR; Rivel ER; Rush K
J Chromatogr; 1988 Jun; 428(1):113-21. PubMed ID: 2902101
[TBL] [Abstract][Full Text] [Related]
2. High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine.
Randolph WC; Osborne VL; Walkenstein SS; Intoccia AP
J Pharm Sci; 1977 Aug; 66(8):1148-50. PubMed ID: 19614
[TBL] [Abstract][Full Text] [Related]
3. Determination of famotidine in human plasma by high performance liquid chromatography with column switching.
Zhong L; Yeh KC
J Pharm Biomed Anal; 1998 Feb; 16(6):1051-7. PubMed ID: 9547709
[TBL] [Abstract][Full Text] [Related]
4. Determination of roxatidine in human plasma, urine and milk by capillary gas chromatography using nitrogen-selective detection.
Burrows JL; Jolley KW; Sullivan DJ
J Chromatogr; 1988 Nov; 432():199-208. PubMed ID: 2906063
[TBL] [Abstract][Full Text] [Related]
5. Determination of famotidine in low-volume human plasma by normal-phase liquid chromatography/tandem mass spectrometry.
Zhong L; Eisenhandler R; Yeh KC
J Mass Spectrom; 2001 Jul; 36(7):736-41. PubMed ID: 11473396
[TBL] [Abstract][Full Text] [Related]
6. Gas chromatographic and high-performance liquid chromatographic methods for the determination of genaconazole in biological fluids.
Kim H; Lapiguera A; Lin C
J Chromatogr B Biomed Appl; 1994 Apr; 655(1):21-6. PubMed ID: 8061829
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic determination of a new H2 blocker (ORF 17 910) in plasma.
Huang SM; Tran-Phan H
J Chromatogr; 1987 Dec; 423():358-64. PubMed ID: 2895116
[No Abstract] [Full Text] [Related]
8. Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine.
Vincek WC; Constanzer ML; Hessey GA; Bayne WF
J Chromatogr; 1985 Mar; 338(2):438-43. PubMed ID: 2860117
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics of famotidine in man.
Kroemer H; Klotz U
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):458-63. PubMed ID: 2888738
[TBL] [Abstract][Full Text] [Related]
10. HPLC fluorescence method for the determination of nizatidine in human plasma and its application to pharmacokinetic study.
Çakar MB; Ulu ST
Luminescence; 2014 Jun; 29(4):357-61. PubMed ID: 23836529
[TBL] [Abstract][Full Text] [Related]
11. High performance liquid chromatographic determination of a new antifungal compound, ADKZ in rat plasma.
Wen J; Fan GR; Hong ZY; Chai YF; Yin XP; Wu YT; Sheng CQ; Zhang WN
J Pharm Biomed Anal; 2007 Jan; 43(2):655-8. PubMed ID: 16950589
[TBL] [Abstract][Full Text] [Related]
12. The assay of a novel histamine H2-receptor antagonist, SK&F 93479, in human plasma by normal-phase high-performance liquid chromatography.
McDowall RD; Lee RM
J Chromatogr; 1983 Jul; 275(2):377-85. PubMed ID: 6137490
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a sensitive LC-MS/MS assay for the quantification of nizatidine in human plasma and urine and its application to pharmacokinetic study.
Shang DW; Wang ZZ; Ni XJ; Zhang M; Hu JQ; Qiu C; Wen YG
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():80-7. PubMed ID: 26197435
[TBL] [Abstract][Full Text] [Related]
14. [Determination of new H2-receptor antagonist Z-300 in plasma by high-performance liquid chromatography with fluorescence detection].
Hoshino M; Watanabe Y; Hamasaki Y; Masubuchi M; Okahira A
Yakugaku Zasshi; 1993 Aug; 113(8):586-90. PubMed ID: 8104246
[TBL] [Abstract][Full Text] [Related]
15. Gas-liquid chromatographic resolution of some racemic synthons for lamtidine analogous histamine H2-receptor antagonists via diastereomeric amides of (1S)-(-)-camphanic acid.
Büyüktimkin N; Keller F; Schunack W
J Chromatogr; 1989 Apr; 467(2):402-5. PubMed ID: 2569470
[No Abstract] [Full Text] [Related]
16. Analysis of ranitidine in serum by high performance liquid chromatography.
Vandenberghe HM; MacLeod SM; Mahon WA; Lebert PA; Soldin SJ
Ther Drug Monit; 1980; 2(4):379-84. PubMed ID: 6111854
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic assay for nizatidine, a new H2 blocker, in human plasma and urine using disposable solid-phase extraction columns.
Carlucci G
J Chromatogr; 1990 Feb; 525(2):490-4. PubMed ID: 1970345
[No Abstract] [Full Text] [Related]
18. [High pressure liquid-liquid chromatography. Quantitative determination of histamine H2 antagonists].
Gaetani E; Laureri CF; Ronchini F
Farmaco Prat; 1978 Nov; 33(11):484-8. PubMed ID: 35364
[No Abstract] [Full Text] [Related]
19. Determination of nizatidine and two of its main metabolites in human serum using high-performance liquid chromatography.
Tracqui A; Kintz P; Mangin P
J Chromatogr; 1990 Aug; 529(2):369-76. PubMed ID: 1977754
[TBL] [Abstract][Full Text] [Related]
20. An automated method for the determination of a new potential antiepileptic agent (CGP 33101) in human plasma using high performance liquid chromatography.
Brunner LA; Powell ML
Biomed Chromatogr; 1992; 6(6):278-82. PubMed ID: 1286284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
